Autonomix Medical (AMIX) Liabilities and Shareholders Equity (2023 - 2025)

Autonomix Medical (AMIX) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $10.2 million in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $10.2 million, down 14.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $36.9 million (up 9.23% YoY), and the FY2025 annual result was $9.8 million, up 4.24% from the prior year.
• Liabilities and Shareholders Equity improved to $10.2 million in Q4 2025 per AMIX's latest filing, from $7.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $12.0 million in Q4 2024 and troughed at $865000.0 in Q1 2023.
• A 3-year average of $7.3 million and a median of $8.5 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity soared 987.51% in 2024, then retreated 14.57% in 2025.
• A 3-year view of Liabilities and Shareholders Equity shows it stood at $1.8 million in 2023, then jumped by 560.7% to $12.0 million in 2024, then decreased by 14.57% to $10.2 million in 2025.
• Business Quant data shows AMIX's Liabilities and Shareholders Equity at $10.2 million in Q4 2025, $7.9 million in Q3 2025, and $9.0 million in Q2 2025.